A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

PubWeight™: 3.93‹?› | Rank: Top 1%

🔗 View Article (PMID 7619183)

Published in Lancet on March 04, 1995

Authors

P Farrington1, S Pugh, A Colville, A Flower, J Nash, P Morgan-Capner, M Rush, E Miller

Author Affiliations

1: Public Health Laboratory Service Statistics Unit, Communicable Disease Surveillance Center, London, UK.

Articles citing this

Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ (2001) 4.50

Concerns about immunisation. BMJ (2000) 2.80

Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax (2005) 1.71

Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits. CMAJ (1996) 1.69

MMR vaccine: the continuing saga. BMJ (2001) 1.27

MMR vaccine--worries are not justified. Arch Dis Child (2001) 1.22

A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health (2001) 1.20

Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child (2001) 1.17

Emerging vaccine informatics. J Biomed Biotechnol (2011) 1.12

Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control (2005) 1.10

MMR: where are we now? Arch Dis Child (2007) 1.02

Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Br J Clin Pharmacol (2008) 1.01

Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis. PLoS One (2009) 1.01

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. PLoS One (2008) 0.96

What should an ideal vaccine postlicensure safety system be? Am J Public Health (2009) 0.89

Feasibility study for identifying adverse events attributable to vaccination by record linkage. Epidemiol Infect (1995) 0.85

Association between socioeconomic status and adverse events following immunization at 2, 4, 6 and 12 months. Hum Vaccin Immunother (2013) 0.83

Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax (2003) 0.83

Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysis. PLoS One (2011) 0.82

Revaccination against measles and rubella. BMJ (1996) 0.82

The "urban myth" of the association between neurological disorders and vaccinations. J Prev Med Hyg (2015) 0.81

Association between birth order and emergency room visits and acute hospital admissions following pediatric vaccination: a self-controlled study. PLoS One (2013) 0.81

Use of the self-controlled case series method in drug safety assessment. Expert Opin Drug Saf (2011) 0.81

Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study. PLoS One (2013) 0.80

Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study. PLoS One (2013) 0.80

Enhancing vaccine safety capacity globally: A lifecycle perspective. Vaccine (2015) 0.75

Active surveillance for vaccine adverse effects. Lancet (1995) 0.75

Childhood immune thrombocytopenia: Clinical presentation and management. Sudan J Paediatr (2012) 0.75

Annual report on adverse events related with vaccines use in Calabria (Italy): 2012. J Pharmacol Pharmacother (2013) 0.75

DVT and pulmonary embolism after acute infection. Lancet (2006) 0.75

National measles and rubella vaccination campaign. BMJ (1995) 0.75

The use of relative incidence ratios in self-controlled case series studies: an overview. BMC Med Res Methodol (2016) 0.75

Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants. PLoS One (2016) 0.75

Factors associated with mumps meningitis and the possible impact of vaccination. Korean J Pediatr (2016) 0.75

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review. BMC Med Res Methodol (2017) 0.75

Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012. J Prev Med Hyg (2014) 0.75

Writing a Research Proposal to The Research Council of Oman. Oman Med J (2017) 0.75

Articles by these authors

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10

The new measles campaign. BMJ (1994) 6.59

Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet (1993) 5.53

Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J Cell Biol (2001) 5.05

Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86

Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60

Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56

Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst (1977) 4.28

Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18

Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13

Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10

Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature (1968) 3.62

Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet (2001) 3.19

SEX DIFFERENCES IN KIDNEY MORPHOLOGY AND CHLOROFORM NECROSIS. Science (1945) 3.18

Surveillance of antibody to measles, mumps, and rubella by age. BMJ (1988) 3.11

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet (1993) 3.08

Treatment of Early Mammary Carcinoma: A Cooperative International Study. Ann Surg (1963) 3.07

PDZ domains in synapse assembly and signalling. Trends Cell Biol (2000) 2.96

Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81

Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81

Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol (1996) 2.65

Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol (1974) 2.57

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57

Rubella vaccination in the UK: time for a complete strategy. Lancet (1985) 2.54

Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51

Varicella-zoster virus epidemiology--a changing scene? J Infect Dis (1996) 2.48

Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) (1985) 2.48

Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48

Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48

Shift in age in chickenpox. Lancet (1993) 2.46

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A (1995) 2.44

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet (1994) 2.43

Cell position and light influence C4 versus C3 patterns of photosynthetic gene expression in maize. EMBO J (1988) 2.37

Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) (2001) 2.37

Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis (2000) 2.35

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33

The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32

A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32

Mumps meningitis and measles, mumps, and rubella vaccine. Lancet (1992) 2.30

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis (1998) 2.26

The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25

Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis (1999) 2.16

Varicella in maternity units. Lancet (1990) 2.16

Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J (Clin Res Ed) (1987) 2.13

A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol (1999) 2.09

Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis (1999) 2.04

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem (2000) 2.02

Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01

Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99

Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev (1997) 1.97

Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol (1996) 1.90

Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89

Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 1.88

Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.88

Vasopressin in prevention of lumbar puncture headache. Br Med J (1968) 1.85

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ (2010) 1.83

Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80

The Support of Research in Medical and Allied Fields for the Period 1946 through 1951. Science (1952) 1.80

Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79

Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol (2002) 1.77

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75

A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71

Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69

Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA (1971) 1.68

Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child (1984) 1.67

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67

Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol (1993) 1.66

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65

Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract (2001) 1.64

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64

Surveillance of symptoms following MMR vaccine in children. Practitioner (1989) 1.63

Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63

Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62

The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60

From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59

Traditional and emerging forms of dental practice. Cost, accessibility, and quality factors. Am J Public Health (1982) 1.57

Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis (1988) 1.57

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol (1998) 1.57

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol (2000) 1.55

Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet (1987) 1.54